You are here

Ibrance

Pfizer, Arvinas Post Upbeat Data From Breast Cancer Study

NASDAQ

Thu, 05/16/24 - 09:54 pm

clinical trials

There's a Silver Lining in Pfizer's Dark Cloud

Motley Fool

Fri, 11/3/23 - 10:56 am

In mysterious FDA approval, Pfizer quietly wins Ibrance breast cancer expansion

Fierce Pharma

Tue, 01/31/23 - 11:11 pm

Pfizer and Erasca Target Pancreatic, Colorectal Cancer with "Synergistic" Pairing

BioSpace

Thu, 10/20/22 - 11:24 pm

colorectal cancer

Pfizer's Ibrance Fails to Significantly Extend Lives of Breast Cancer Patients

BioSpace

Mon, 06/6/22 - 11:48 pm

HER2-negative breast cancer

ASCO: Pfizer's Ibrance fails to extend lives in newly diagnosed breast cancer. Will doctors switch gears to Novartis, Lilly?

Fierce Pharma

Sun, 06/5/22 - 11:40 pm

HER2-negative breast cancer

clinical trials

Bristol Myers Squibb, Amgen and Pfizer approach steepest patent cliffs among large drugmakers

Fierce Pharma

Fri, 12/31/21 - 11:10 am

Bristol Myers Squibb

ESMO: Syros targets KRAS-mutant cancer as CDK7 inhibitor shows early promise

Fierce Biotech

Mon, 09/20/21 - 12:00 pm

Syros Pharmaceuticals

The top 15 blockbuster patent expirations coming this decade

Fierce Pharma

Mon, 07/12/21 - 11:08 am

Pfizer's Ibrance, under threat from Novartis and Lilly, leans on real-world data in breast cancer

Fierce Pharma

Mon, 03/29/21 - 10:37 am

Immuno-Oncology Treatments Finding Success with Combination Therapies

BioSpace

Thu, 03/25/21 - 11:44 am

immuno-oncology

Bristol-Myers Squibb

clinical trials

Ibrance trial failure dashes Pfizer’s growth hopes for the drug

Pharmaforum

Sun, 10/11/20 - 10:23 pm

Pfizer's breast cancer drug Ibrance fails late-stage study

Reuters

Fri, 10/9/20 - 10:58 am

clinical trials

ESMO: Lilly's Verzenio pressures Pfizer with practice-changing win in early breast cancer

Fierce Pharma

Sun, 09/20/20 - 07:54 pm

Cut-price drug venture takes aim at Pfizer and Astrazeneca

EP Vantage

Fri, 07/24/20 - 09:27 am

Pfizer's Ibrance misses shot at big new market with early breast cancer failure

Fierce Pharma

Sun, 05/31/20 - 11:55 pm

clinical trials

HER2-negative breast cancer

Three Breast Cancer Drugs: FDA Warns of Rare but Serious Lung Inflammation

RAPS.org

Sun, 09/15/19 - 09:47 pm

Pfizer points to newer meds—including Ibrance—as post-Upjohn cash engines

Fierce Pharma

Tue, 07/30/19 - 11:00 pm

FDA Approves Pfizer’s Ibrance in Men With Breast Cancer

BioSpace

Fri, 04/5/19 - 12:06 pm

male breast cancer

Pfizer works to get 'wait-and-see' doctors on board the Ibrance train

Fierce Pharma

Fri, 10/26/18 - 11:55 am

Pages